Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06957041

Intertransverse Process Block for Quality of Recovery Post-Open Hepatectomy

Effect of Intertransverse Process Block on the Quality of Recovery Post-Open Hepatectomy: A Pilot Non-Randomised Study of Intervention

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The study aims to assess the analgesic efficacy of the ITPB at the retro-SCTL space in patients undergoing major open hepatectomy surgery. This is assessed by: Primary Objective: Primary outcome measure: ● Assessing the quality of recovery 15 (QoR15) score at 24 and 48 hours Secondary outcome measure: * Number of anaesthetic and hypoesthetic dermatomes on the ventral and dorsal aspect of the thorax on both the sides at 30 minutes of block completion and during the post anaesthetic room (PACU) discharge * Assessing the 24-hour area under the curve of postoperative pain numerical rating score (NRS, 0-10) at rest and deep breathing or upon use of triflow. * Assessing the amount of postoperative morphine (mg) equivalent consumption at 24 and 48 hours * Time to discharge from High dependency unit (HDU) or Intensive care unit (ICU) Hypothesis: The investigators hypothesize that the application of ITPB targeting the retro-SCTL space in patients undergoing open hepatectomy will improve overall quality of recovery and pain score.

Conditions

Interventions

TypeNameDescription
PROCEDUREIntertransverse process blockThe patient(s) will receive a pre-induction Intertransverse process block as pilot study

Timeline

Start date
2025-05-01
Primary completion
2026-07-01
Completion
2026-10-01
First posted
2025-05-04
Last updated
2025-05-04

Source: ClinicalTrials.gov record NCT06957041. Inclusion in this directory is not an endorsement.